zintick

Heron Therapeutics HRTX

Heron Therapeutics, Inc. /DE/ · Nasdaq · Pharmaceutical Preparations

$0.36-2.89%close on Nov. 11, 2026 · volume 4.7M · Yahoo Finance

Price, last 57 sessions

$0.30$0.35$0.40Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 11, 2026 · high $0.42 · low $0.27 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 20 →
  • 4Nov. 10, 2026, 11:24 a.m. ETView on SEC.gov
  • 10-QNov. 9, 2026, 8:50 a.m. ETView on SEC.gov
  • 8-KNov. 9, 2026, 8:15 a.m. ETView on SEC.govOur explainer

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedHeron Therapeutics Q3 2026 revenue of $35.3 million misses $37.5 million consensus; EPS -$0.03 vs -$0.025 expected; no guidance, company selling substantially all assets to CorMedix

  • 8-KNov. 9, 2026, 7:40 a.m. ETView on SEC.gov

    Entry into a material definitive agreement · Material modification of security holders' rights · Regulation FD disclosure · Financial statements and exhibits

    AI summary, unreviewedHeron Therapeutics to Sell Substantially All Assets to CorMedix for $145.0 Million Cash Plus 14,583,333 CorMedix Shares, Wind Down Operating Business

  • 4Nov. 3, 2026, 12:57 p.m. ETView on SEC.gov
  • 4Nov. 3, 2026, 12:54 p.m. ETView on SEC.gov
  • 4Nov. 3, 2026, 12:53 p.m. ETView on SEC.gov
  • 4Nov. 3, 2026, 12:50 p.m. ETView on SEC.gov